Galectin Therapeutics Inc.
GALT
$3.98
-$0.18-4.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -3.40% | 7.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -41.43% | -36.46% | |||
| Operating Income | 41.43% | 36.46% | |||
| Income Before Tax | 21.91% | 19.52% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 21.91% | 19.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 21.91% | 19.52% | |||
| EBIT | 41.43% | 36.46% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 21.38% | 20.71% | |||
| Normalized Basic EPS | 22.16% | 20.13% | |||
| EPS Diluted | 21.38% | 20.71% | |||
| Normalized Diluted EPS | 22.16% | 20.13% | |||
| Average Basic Shares Outstanding | 0.38% | 0.73% | |||
| Average Diluted Shares Outstanding | 0.38% | 0.73% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||